Chemed Corporation (CHE) - Stock Analysis
Last updated: Apr 25, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Healthcare services beat-and-raise candidate: Q1 2026 revenue and adjusted EPS beat estimates, full-year guidance was raised, VITAS growth remained strong with admissions up 6.9%, and the company added a new $300M buyback authorization.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong margins ⢠Healthy cash flow ⢠Low leverage CHE combines strong profitability, solid cash generation, and low leverage, but its moderate liquidity and full valuation temper the investment case.
Price Behavior
Key Price Behavior Insights: ⢠Breakout confirmation ⢠Key support hold ⢠Short-term overextension Support Level: $373â$377 Resistance Level: $390â$395 CHE is constructive over the last month after breaking above the $390â$395 resistance zone, but it may be short-term overextended and needs to hold above the $373â$377 support area to confirm the breakout.
Sentiment & News
Key News Insights: ⢠Earnings beat ⢠VITAS strength ⢠Roto weakness Chemed's shares were pressured ahead of earnings, but Q1 2026 results beat estimates, VITAS strength drove a guidance raise, and capital actions plus acquisitions support the long-term outlook.
AI Summary
CHE should now be viewed less as a cap-risk turnaround and more as a VITAS-led quality compounder, with the key question being whether hospice growth and cash generation can outpace Roto-Rooter's margin drag and support a still-premium valuation; the upside is intact, but execution at VITAS and stabilization in Roto-Rooter are now the decisive catalysts.
Description
Chemed Corporation delivers hospice and palliative care through a multidisciplinary network of clinicians, aides, social workers, clergy and volunteers across the United States under its VITAS segment, and provides plumbing, drain, excavation and water-restoration services to residential and commercial customers via company branches, independent contractors and franchisees under its Roto-Rooter segment. The company operates these two distinct businesses from its headquarters in Cincinnati and has been incorporated since 1970.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 28 | May 5 | CHE | Chemed Corporation | Healthcare services beat-and-raise candidate: Q1 2026 revenue and adjusted EPS beat estimates, full-year guidance was raised, VITAS growth remained strong with admissions up 6.9%, and the company added a new $300M buyback authorization. | Active | +0.0% |